T he current national focus on drug abuse is reflected in daily newspapers, magazine articles, and professional journals. A quote from a local Maryland magazine regarding a 1987train disaster dramatically conveys an insight into the public understanding of the many complex issues of public safety and substance abuse on the job.
Destination: Disaster Sixteen died in last January's fiery Amtrak crash north of Baltimore. Is one freight train engineer totally to blame? For ten years rail leaders squabbled over a safety system that would have stopped the crash. And new evidence shows drug programs were powerless against the freight crew's getting high on the job.
Baltimore Magazine. November 1987 Many factors, occurring in various combinations, act as catalysts for employers seeking solutions to perceived drug abuse problems in their workplaces. As illustrated, the stimulus for action relating to substance abuse may involve accidents and disasters resulting from breaches in safety procedures. In addition, poor labor-management relations, decreased produc- tivity, higher absenteeism, increased accident rates, and/or observed drug abuse or drug dealings at the worksite may influence an employer to consider a variety of alternatives (Bompey, 1986; Dogoloff, 1985; MacDonald, 1986) . Given President Reagan's endorsement of urine drug testing for federal employees and his encouragement of such testing in the private sector, urine drug testing has become a workable option for concerned employers.
Are employers legitimately concerned that illegal or unauthorized substance abuse results in enormous costs to industry or are employers seizing upon a new mechanism to terminate employees? Statistics suggest that the problem of drug abuse is growing and expanding in the workplace. industry (MacDonald, 1986) . The costs related to production may include reduced performance, increased turnover and retraining costs, increased injury rates, additional absenteeism, and higher medical costs. There may be additional labor-related costs, such as added grievances, arbitrations, and thefts (Assareh, 1987; Bompey, 1986; Dupont, 1980) . Psychological costs (which are not quantifiable) are borne by everyone, particularly co-workers, families, and society. Furthermore, the longer an addicted individual remains unidentified, the greater the costs for treatment and rehabilitation.
Reactive approaches involve actions that occur after a troubled employee has been identified, with impaired behavior incurring extreme costs, such as those described (Pandina, 1986) . Conversely, industry may develop a proactive program for ultimately minimizing substance abuse and related effects on the workplace. Through the guidance of occupational health professionals, proactive substance abuse surveillance
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Continued/rom page Jl9 programs can be developed and implemented with a primary focus on preventive strategies. Proactive surveillance for substance abuse involves tests, procedures, and examinations which can be administered to working populations in an objective, consistent manner to promote the health and welfare of employee and employer alike.
In the authors' experience, many of the established purposes of health surveillance within occupational health practice complement the purposes for conducting urine drug screening:
• To complete routine measurements of employee health status that may serve as baseline comparisons.
• To identify new employees with preexisting functional impairment for purposes of appropriate job placement.
• To identify safety and health risks not previously recognized so that steps can be taken for control.
• To detect health changes in the early stages when corrective measures and preventive actions are most effective.
• As a component in evaluating various occupational health intervention strategies and programs. "Urine drug screening" includes those activities involving the collection of urine to test for metabolites of illicit, prescription, and over-the-counter drugs. Ethyl alcohol mayor may not be included. As stated by the American Occupational Medical Association in 1986, urine drug screening can include "pre-employment assessment, periodic mandatory medical surveillance, special work fitness examinations, and monitoring of employees who are under treatment for drug abuse as a condition of continued employment. "
Currently, urine drug screening is a popular method for solving the problem of drug abuse at the worksite. Surveillance programs focusing on prevention and early detection of employees who abuse drugs mayor may not incorporate urine drug screening. A proactive, preventive surveillance approach in high risk industries incorporates effective screening procedures and referral criteria. It is designed with input from management, legal counselors, occupational health professionals, and rehabilitation consultants (including Employee Assistance Pro-
The courts have recognized that a company has legal grounds for formulating a policy on drug abuse. gram counselors). Primary prevention strategies also include education regarding treatment interventions, available resources, and alternatives for deterring substance abuse behaviors.
A company philosophy and policy for substance abuse establishes both a practical framework and the legal basis for conducting a drug screening program. Written procedures should be developed prior to initiating such a program. Legally, the program must be non-discriminatory; all employees should be included, subject to the same testing, and referred consistently (Bompey, 1986; Cross, 1987) . Another key issue is confidentiality. Ethically and legally, confidentiality of screening results should be clear and concise when incorporated into the policy and procedure document adopted by the company (Assareh, 1987) .
As summarized by Assareh (1987) , the courts throughout the country have recognized that a company has legal grounds for formulating a policy on drug and alcohol abuse, namely, the public's trust, the public's safety, and an employee's fitness for duty. Purposes for drug screening are:
• To detect employees who may be abusing alcohol and/or illegal substances prior to employment. • To determine fitness for duty both pre-employment and while employed.
• To protect the affected employee, coworkers, and the public from the consequences of impaired performance.
• As a tool for confirming suspected intoxication or impairments related to drug or alcohol abuse along with other parameters such as absenteeism, productivity, or erratic behavior.
• As a deterrent to potential abusers of drugs or alcohol.
• As a mechanism of referral to rehabilitation and treatment programs for employees who abuse drugs or alcohol.
• To complement consistent policies regarding substance abuse on the job, the sale of illegal substances at work, and arriving for work under the influence of intoxicating substances.
Other criteria for implementing screening programs include cost-effectiveness, employee acceptance, and availability of accessible follow-up resources. If management weighs the costs of implementing an effective drug surveillance program against the costs incurred from drug abuse, the course of action will be clearer. Furthermore, employee opinion influences such considerations. Will there be law suits? Will employees utilize the available referral resources? For that matter, can management afford to provide recognized, acceptable resources for referral and rehabilitation?
The selected screening tests must be reliable and reproducible for a drug screening program to be effective. The methods and services of toxicological laboratories must be compared and evaluated. Laboratory performance must be judged by the types of testing equipment, and the sensitivity, specificity, and validity of the test methods. The selected laboratory's policies and procedures on confidentiality, confirmation testing, and definitions for positive and negative results should be clearly stated. Schnoll and Lewis (1986) have summarized a comparison of analytical techniques that may be helpful when choosing a laboratory.
Urine is considered an appropriate body fluid to test for evidence of drug metabolites. The advantages of urine drug testing include the ready availability of urine, the non-invasive nature of specimen collection, the concentration of drug metabolites in the urine, and the ease of testing an aqueous material. The primary disadvantage is that there is no correlation between urine concentration of drug metabolite and physiological or behavioral effects.
Consistent and meticulous collection techniques are critical to a reliable and valid urine drug screening program. If chain of custody is documented each time the specimen changes hands, the specimen results are less subject to question. Furthermore, personnel require thorough instruction in collection techniques, labeling procedures, documentation, and strategies for handling confrontive employees. These procedures decrease the likelihood of substituting or tampering with specimens and increase the likelihood of withstanding a court challenge.
If the urine drug screening program includes a health assessment component, administration of a questionnaire (designed to elicit health conditions for which the employee takes prescription and over-the-counter medications) assists the occupational health professional in evaluating positive test results. We recognize the dualistic nature of the urine drug testing controversy in the workplace. For many, the invasion of privacy and other ethical issues preclude the use of urine drug testing at all.
The selected screening tests must be reliable and reproducible for a drug screening program to be effective.
On the other hand, urine drug testing programs where philosophy, purposes, and procedures are not explicitly stated and scrupulously adhered to can damage employee-employer relations, provoke law suits, and impinge on individual rights. As managers of surveillance programs in industry, occupational health nurses can influence the manner in which companies screen employees for evidence of substance abuse. This guidance can ensure that substance abuse screening programs accomplish their stated purposes in a non-punitive and confidential fashion. Outcomes, such as increased productivity, successful rehabilitation, and accident prevention benefit individuals, industry, and society. An appropriate, presumptive identification of substance abuse through comprehensive, proactive surveillance strategies emphasizes the role of employers in preventing drug abuse and drug-related problems at the worksite.
